Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
1J-tube----[1] 6 💬
2J01gb01----[1] 299 💬
3J05A F01----[1] 135 💬
4J06ba02----[1] 309 💬
5J1081----[1] 56 💬
6J695----[1] 96 💬
7J695, BSF 415977 (formerly LU415977), WAY-165772, A-796874.0----[1] 96 💬
8JAK 3----[1] 46 💬
9JAK 3 ritlecitinib----[1] 46 💬
10JAK inhibitor----[4] 46, 50, 97, 325 💬
11JAK1 / JAK2 inhibitor----[1] 46 💬
12JAK1 / JAK2 inhibtor----[1] 46 💬
13Jaki----[1] 46 💬
14Jaktinib[1] Jaktinib---[1] 271 💬
15Jaktinib hydrochloride tablets[1] Jaktinib---[2] 85, 271 💬
16Janus kinase inhibitor----[4] 46, 97, 110, 162 💬
17Jardiance[1] Empagliflozin[1] Empagliflozin 💬 --[2] 65, 86 💬
18Jbpos0101[1] JBPOS0101---[1] 145 💬
19JBT-101[1] Lenabasum[1] Lenabasum 💬 [1] CNR2 💬 [1] Neuroactive ligand-receptor interaction 💬[4] 49, 50, 51, 299 💬
20JBT101----[1] 299 💬
21JE049----[1] 65 💬
22Jejunal extension tube----[1] 6 💬
23Jevity 1.0----[1] 2 💬
24Jevity 1.5----[1] 2 💬
25JH-DSA SEMI-quant screen and response score----[1] 60 💬
26JHL1101----[1] 46 💬
27Jianpixiaozhong particles and wuse dietotherapy----[1] 222 💬
28JIN-shui HUAN-xian granule----[1] 85 💬
29Jinarc[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
30Jinarc - 15 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
31Jinarc - 30 MG - compressa - USO orale - blister (ALU/PVC) - 28 compresse[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
32Jinarc - tolvaptan tablets[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
33Jinarc 15 MG tablets, jinarc 45 MG tablets[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
34Jinarc 30 MG tablet[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
35Jinarc 30 MG tablets, 90 MG tablets[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
36Jinarc 30 MG tablets, jinarc 60 MG tablets[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
37Jinarc® 15MG tablet[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
38Jinarc® 30 tablet[1] Tolvaptan[1] Tolvaptan 💬 [1] AVPR2 💬 [4] Hormone signaling, Neuroactive ligand-receptor interaction, Phospholipase D signaling pathway, Vasopressin-regulated water reabsorption 💬[1] 67 💬
39Jing SI herbal TEA liquid packets----[2] 46, 271 💬
40JKB-122----[1] 95 💬
41JKB-122 IN capsule or tablet form----[1] 95 💬
42JM-010----[1] 6 💬
43JM-010 group A----[1] 6 💬
44JM-010 group B----[1] 6 💬
45JM-4----[1] 13 💬
46JMKX000189----[1] 49 💬
47JMKX003142 will BE administered orally----[1] 67 💬
48JNJ 38518168----[1] 46 💬
49JNJ 54767414----[1] 28 💬
50JNJ-16240159-AAC----[1] 46 💬
51JNJ-31001074----[1] 6 💬
52JNJ-38518168----[1] 46 💬
53JNJ-38518168 / MTX----[1] 46 💬
54JNJ-38518168 50-MG over encapsulated tablet----[1] 46 💬
55JNJ-38518168-AEK - over encapsulated tablet - 50 MG----[1] 46 💬
56JNJ-38518168-ZBQ - FILM-coated tablet - 10 MG----[1] 46 💬
57JNJ-38518168-ZBQ - FILM-coated tablet - 10MG----[1] 46 💬
58JNJ-38518168-ZBQ - FILM-coated tablet - 3 MG----[1] 46 💬
59JNJ-38518168-ZBQ - FILM-coated tablet - 30 MG----[1] 46 💬
60JNJ-38518168-ZBQ - FILM-coated tablet - 30MG----[1] 46 💬
61JNJ-38518168-ZBQ - FILM-coated tablet - 3MG----[1] 46 💬
62JNJ-39039039----[1] 210 💬
63JNJ-39758979[1] JNJ-39758979---[1] 46 💬
64JNJ-39758979 / MTX[1] JNJ-39758979---[1] 46 💬
65JNJ-39758979-AAC - enteric coated tablet - 10 MG[1] JNJ-39758979---[1] 46 💬
66JNJ-39758979-AAC - enteric coated tablet - 100 MG[1] JNJ-39758979---[1] 46 💬
67JNJ-39758979-AAC - enteric coated tablet - 30 MG[1] JNJ-39758979---[1] 46 💬
68JNJ-40346527[1] JNJ-40346527---[1] 46 💬
69JNJ-40346527-AAC[1] JNJ-40346527---[1] 96 💬
70JNJ-40346527-AAC - capsule - 50 MG[1] JNJ-40346527---[1] 46 💬
71JNJ-42160443----[1] 226 💬
72JNJ-54767414----[2] 28, 49 💬
73JNJ-54781532 150 MG once daily----[1] 97 💬
74JNJ-54781532 25 MG once daily----[1] 97 💬
75JNJ-54781532 75 MG once daily----[1] 97 💬
76JNJ-54781532 75 MG twice daily----[1] 97 💬
77JNJ-54781532-AAD-10 MG----[1] 97 💬
78JNJ-54781532-AAD-30 MG----[1] 97 💬
79JNJ-54781532-AAD-5 MG----[1] 97 💬
80JNJ-55920839----[1] 49 💬
81JNJ-56022473----[1] 49 💬
82JNJ-64304500----[1] 96 💬
83JNJ-64304500-AAA----[1] 96 💬
84JNJ-64841829----[1] 97 💬
85JNJ-64841842----[1] 97 💬
86JNJ-64841855----[1] 97 💬
87JNJ-64841894----[1] 97 💬
88JNJ-64841907----[1] 97 💬
89JNJ-64841920----[1] 97 💬
90JNJ-64841933----[1] 97 💬
91JNJ-64841946----[1] 97 💬
92JNJ-66525433----[1] 97 💬
93JNJ-67484703----[1] 46 💬
94JNJ-67864238----[1] 96 💬
95JNJ-67896049----[1] 86 💬
96JNJ-67896062 / ACT-064992----[2] 86, 88 💬
97JNJ-67896062/ACT-064922----[1] 86 💬
98JNJ-67896153/ACT-128800----[1] 13 💬
99JNJ-72537634----[1] 97 💬
100JNJ-77242113----[2] 37, 97 💬
101JNJ-78934804----[2] 96, 97 💬
102JNJ-79635322----[1] 28 💬
103JNJ-80202135----[4] 11, 46, 49, 53 💬
104JNJ31-31001074----[1] 6 💬
105JNT-517 suspension[1] JNT-517---[1] 240 💬
106JNT-517 tablet[1] JNT-517---[1] 240 💬
107Joint puncture----[1] 107 💬
108Jojoba OIL with broccoli sprout extract[1] Jojoba oil---[1] 36 💬
109Jorveza[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
110Jorveza 0.5 MG compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
111Jorveza 0.5 MG orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
112Jorveza 1 MG compresse orodispersibili[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
113Jorveza 1 MG orodispersible tablets[1] Budesonide[1] Budesonide 💬 [1] NR3C1 💬 [1] Neuroactive ligand-receptor interaction 💬[1] 98 💬
114JP 1730----[1] 6 💬
115JP-1730/F01----[2] 6, 17 💬
116JP-1730/F02----[2] 6, 17 💬
117JP-1730/F03----[2] 6, 17 💬
118JR-141----[1] 19 💬
119JR-141 or idursulfase[1] Idursulfase[1] Idursulfase 💬 [1] IDS 💬 [2] Glycosaminoglycan degradation, Lysosome 💬[1] 19 💬
120JR-171----[1] 19 💬
121JR-441----[1] 19 💬
122JR-446----[1] 19 💬
123JS002----[1] 79 💬
124JS005----[1] 271 💬
125JSP191----[2] 65, 285 💬
126JTE-051----[1] 46 💬
127JTT-251[1] JTT-251---[1] 86 💬
128Juanbi pill----[1] 46 💬
129Juvit D3----[1] 6 💬
130JWK006----[1] 301 💬
131JWK007 single intravenous infusion administration----[1] 113 💬
132JWK008 single intravenous infusion administration----[1] 19 💬
133JX2105----[1] 6 💬
134JY231 injection----[1] 49 💬
135JYP0061----[1] 13 💬
136Jyseleca[1] Filgotinib[2] Filgotinib ,
Filgotinib maleate 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[2] 46, 97 💬
137Jyseleca 100 MG FILM-coated tablets[1] Filgotinib[2] Filgotinib ,
Filgotinib maleate 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
138Jyseleca 100MG FILM-coated tablets[1] Filgotinib[2] Filgotinib ,
Filgotinib maleate 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
139Jyseleca 200 MG FILM-coated tablets[1] Filgotinib[2] Filgotinib ,
Filgotinib maleate 💬 		[4] JAK1,
JAK2,
JAK3,
TYK2 💬 		[39] AGE-RAGE signaling pathway in diabetic complications, Adipocytokine signaling pathway, Chemical carcinogenesis - receptor activation, Chemokine signaling pathway, Cholinergic synapse, Coronavirus disease - COVID-19, Efferocytosis, Epstein-Barr virus infection, Growth hormone synthesis, secretion and action, Hepatitis B, Hepatitis C, Herpes simplex virus 1 infection, Hormone signaling, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Human papillomavirus infection, Influenza A, JAK-STAT signaling pathway, Kaposi sarcoma-associated herpesvirus infection, Leishmaniasis, Lipid and atherosclerosis, Measles, NOD-like receptor signaling pathway, Necroptosis, Non-small cell lung cancer, Osteoclast differentiation, PD-L1 expression and PD-1 checkpoint pathway in cancer, PI3K-Akt signaling pathway, Pancreatic cancer, Pathways in cancer, Primary immunodeficiency, Prolactin signaling pathway, Signaling pathways regulating pluripotency of stem cells, Th1 and Th2 cell differentiation, Th17 cell differentiation, Toll-like receptor signaling pathway, Toxoplasmosis, Tuberculosis, Viral carcinogenesis 💬[1] 46 💬
140JZP-110----[1] 6 💬
141JZP385----[1] 6 💬